Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes

BACKGROUND: Escalating trends of obesity and associated type 2 diabetes (T2D) has prompted an increase in the use of alternative and complementary functional foods. Momordica charantia or bitter melon (BM) that is traditionally used to treat diabetes and complications has been demonstrated to allevi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nerurkar, Pratibha V, Lee, Yun-Kung, Nerurkar, Vivek R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911406/
https://www.ncbi.nlm.nih.gov/pubmed/20587058
http://dx.doi.org/10.1186/1472-6882-10-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911406/
https://www.ncbi.nlm.nih.gov/pubmed/20587058
http://dx.doi.org/10.1186/1472-6882-10-34

Ejemplares similares